ENAVATE SCIENCES GP, LLC
Follow13F filer, CIK 1953107, New York, NY
ENAVATE SCIENCES GP, LLC reported $279,763,966 across 8 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001953107-26-000019
- Period
- 2026-09-30
- Reported value
- $280M
- Holdings
- 8
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BRVEnew | +3,674,656 | $74.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ZBIOreduced | -1,000,000 | -$27M |
| CAMPreduced | -384,414 | -$1.55M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001953107-26-000019, largest first. % of portfolio is the value over $279,763,966, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ZBIOZENAS BIOPHARMA INC | 2,919,159 | $78.7M | 28.14% | -1,000,000 | Timeline | ||
| IMNMIMMUNOME INC | 3,613,799 | $77.7M | 27.79% | 0 | Timeline | ||
| BRVEBRAVEHEART BIO INC | 3,674,656 | $74.2M | 26.53% | new | Timeline | ||
| SIONSIONNA THERAPEUTICS INC | 2,478,030 | $13M | 4.66% | 0 | Timeline | ||
| UPBUPSTREAM BIO INC | 2,459,703 | $13M | 4.63% | 0 | Timeline | ||
| BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 2,626,946 | $10.8M | 3.85% | 0 | Timeline | ||
| CMPXCOMPASS THERAPEUTICS INC | 7,788,150 | $8.1M | 2.9% | 0 | Timeline | ||
| CAMPCAMP4 THERAPEUTICS CORP | 1,041,127 | $4.21M | 1.5% | -384,414 | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001953107-26-000019 | base | 2026-11-16 |